Wockhardt to divest its nutrition business to Danone

03 Aug 2011 Evaluate

Wockhardt, a pharmaceutical and biotechnology major and its subsidiary has inked an agreement to divest their nutritional business to Danone, one of the fastest-growing food company in the world. Wockhardt has presence in India's nutritional category with Farex, Dexolac, Nusobee and Protinex. However, the company has retained its nutrition manufacturing facility at Jagraon, Punjab. Further, these transactions are subject to customary closing conditions and various approvals including court approval.

Wockhardt continues to be on the growth track and the strategy to consolidate and rationalize all its core operations is showing encouraging results. The company is re-inventing itself by taking fundamentally strong and positive steps with a firm focus on its core human pharmaceutical business.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s , the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1360.10 28.75 (2.16%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×